Skip to main content
Caplight Logo









Circulogene

Circulogene

Private
Birmingham, AlabamaHealthcare & Life Scienceshttps://circulogene.com/

Last Round

Debt

Mar 24, 2023

Total Funding Raised

$7.99M

Company Overview

Circulogene is a biotechnology company that provides molecular diagnostics and liquid biopsy testing services for the detection and monitoring of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

liquid biopsymolecular diagnosticscomprehensive genomic profilingCGPprecision medicinemolecular residual diseaseMRDcancer genomicslaboratory-developed testsLDTcfDNA analysishereditary cancer testingclinical lab servicesoncology diagnosticsdiagnostic AIcancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Circulogene Comparables

Compare Circulogene with similar companies based on industry and business-model similarity.

Circulogene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lucence
83%
Predicine
81%
Guardant Health
81%

Circulogene Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMar 24, 2023
DebtAug 17, 2022
DebtJan 14, 2021
DebtSep 16, 2019
Early FundingNov 1, 2018
Debt
Sep 20, 2017

Key People

Founding team and executive leadership

Michael Mullen

Chairman and CEO

Executive Team

Chuck Musial

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 94% MoM, from 1.1K to 2.1K.

  • Oct 7, 2025

    Launched OncoGenDx tissue assay for solid tumors.

Circulogene Filings

Explore SEC and related filing metadata, where available.

Circulogene filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Circulogene's valuation, stock price, and market status.

Is Circulogene a public or private company?

Circulogene is a private company.

What is the current stock price of Circulogene?

Circulogene is a private company with no public stock price. No recent secondary market data is available.

How much is Circulogene worth (valuation)?

Valuation information for Circulogene is not publicly available.

Can I buy Circulogene stock?

Circulogene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Circulogene's last funding round?

Circulogene's most recent funding round was Debt on March 24, 2023.

Who are the main investors in Circulogene?

Investor information for Circulogene is not publicly disclosed.

Will Circulogene IPO soon?

No public IPO plans have been announced for Circulogene.

How can I track Circulogene secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Circulogene's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBirmingham, Alabama
Employee Range37
Year Founded2015
Last FundingMar 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?